Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chinook Therapeutics (DE:290A)
FRANKFURT:290A
RESEARCH TOOLSreports
Chinook Therapeutics (290A) Stock Price & Analysis
1 Followers
290A Stock Chart & Stats
Day’s Range€36.4 - €36.6
52-Week Range― - ―
Previous Close€36.4
Volume0.00
Average Volume (3M)N/A
Market Cap
$2.66B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding71,804,977
10 Day Avg. Volume35
30 Day Avg. Volume13
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1429.82
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€37.06Price Target Upside1.81% Upside
Rating ConsensusHold
Number of Analyst Covering12
Chinook Therapeutics News
290A FAQ
What was Chinook Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Chinook Therapeutics’s market cap?
Currently, no data Available
When is Chinook Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Chinook Therapeutics’s earnings last quarter?
Currently, no data Available
Is Chinook Therapeutics overvalued?
According to Wall Street analysts Chinook Therapeutics’s price is currently Undervalued.
Does Chinook Therapeutics pay dividends?
Chinook Therapeutics does not currently pay dividends.
What is Chinook Therapeutics’s EPS estimate?
Chinook Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chinook Therapeutics have?
Currently, no data Available
What happened to Chinook Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Chinook Therapeutics?
Among the largest hedge funds holding Chinook Therapeutics’s share is Baker Bros Advisors LP. It holds Chinook Therapeutics’s shares valued at 34M.
---
Chinook Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Chinook Therapeutics
Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.
---
290A Stock 12 Months Forecast
Average Price Target
€37.06
▲(1.81% Upside)
Technical Analysis
Verastem
―
Crinetics Pharmaceuticals
―
Mirum Pharmaceuticals
―
Magenta Therapeutics
―
Chinook Therapeutics
―
Best Analysts Covering 290A
1 Year
1 Year Success Rate
4/8 ratings generated profit
1 Year Average Return
+11.58%
reiterated a buy rating a year ago
Copying Justin Kim's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +11.58% per trade.
---